Trial Information

Summary: Phase III study for patients with Relapsing remitting Multiple Sclerosis

Patient Inclusion Criteria

  • RRMS
  • Once relapse in last yr or 2 in the last 2 yrs
  • Ambulatory -able to walk length of football field without assistive device

Patient Exclusion Criteria

  • Diabetes
  • Unstable medical condition
  • Low heart rate (< 55 beats/min)

Contact:

Cheryl Rindfleisch, Regulatory Specialist-Coordinator
The Roskamp Institute, Clinical Trials Division
2040 Whitfield Ave.
Sarasota, FL 34243
Telephone: 941-256-8018
Email:

Profile Page: The Roskamp Institute, Clinical Trials Division, Sarasota, FL

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:30:43 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA